<DOC>
	<DOCNO>NCT00530946</DOCNO>
	<brief_summary>To assess change trough Systolic Blood Pressure ( SBP ) percent change Low Density Lipoprotein-Cholesterol ( LDL-C ) baseline Week 8 treatment period</brief_summary>
	<brief_title>A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Amlodipine , atorvastatin drug combination</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>The outpatient concurrent hypertension hyperLDLcholesterolemia male female &gt; =20 &lt; 80 year age Visit 1 . The SBP Visit 4 ( Week 1 ) Visit 5 ( Week 0 ) continuously SBP &gt; =140 mmHg &lt; 180 mmHg , LDLC &gt; =140 mg/dL &lt; 250 mg/dL Visit 3 ( Week 2 ) 4 ( Week 1 ) . Subjects experience follow coronary artery disease within past 3 month . Myocardial infarction Receiving PCI（percutaneous coronary intervention）or CABG ( coronary artery bypass graft ) Any clinically meaningful valvular disease Subjects history cerebrovascular disease stroke transient ischemic attack within past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>